Yang Y, Han J, Perrett H, Richey S, Rodriguez A, Jackson A
Cell Rep. 2024; 43(5):114171.
PMID: 38717904
PMC: 11156625.
DOI: 10.1016/j.celrep.2024.114171.
Zhu Y, Zhu Y, Cao T, Liu X, Liu X, Yan Y
Med Rev (2021). 2023; 3(1):49-74.
PMID: 37724111
PMC: 10471093.
DOI: 10.1515/mr-2023-0001.
Ge P, Ross T
Viruses. 2023; 15(1).
PMID: 36680243
PMC: 9861495.
DOI: 10.3390/v15010203.
Houser K, Chen G, Carter C, Crank M, Nguyen T, Burgos Florez M
Nat Med. 2022; 28(2):383-391.
PMID: 35115706
PMC: 10588819.
DOI: 10.1038/s41591-021-01660-8.
McMillan C, Cheung S, Modhiran N, Barnes J, Amarilla A, Bielefeldt-Ohmann H
NPJ Vaccines. 2021; 6(1):135.
PMID: 34750396
PMC: 8575991.
DOI: 10.1038/s41541-021-00395-4.
Development and application of a real-time RT-PCR assay to rapidly detect H2 subtype avian influenza A viruses.
Xiao Y, Yang F, Liu F, Yao H, Wu N, Wu H
J Vet Diagn Invest. 2021; 33(3):577-581.
PMID: 33618630
PMC: 8120088.
DOI: 10.1177/1040638721994810.
A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade.
Corder B, Bullard B, Poland G, Weaver E
Viruses. 2020; 12(10).
PMID: 33092070
PMC: 7589362.
DOI: 10.3390/v12101186.
Antigenic Change in Human Influenza A(H2N2) Viruses Detected by Using Human Plasma from Aged and Younger Adult Individuals.
Matsuzawa Y, Iwatsuki-Horimoto K, Nishimoto Y, Abe Y, Fukuyama S, Hamabata T
Viruses. 2019; 11(11).
PMID: 31652870
PMC: 6893718.
DOI: 10.3390/v11110978.
The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses.
Linster M, Schrauwen E, van der Vliet S, Burke D, Lexmond P, Bestebroer T
J Virol. 2019; 93(8).
PMID: 30700609
PMC: 6450109.
DOI: 10.1128/JVI.01907-18.
Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment.
Babu T, Perera R, Wu J, Fitzgerald T, Nolan C, Cowling B
J Infect Dis. 2018; 218(7):1054-1060.
PMID: 29762672
PMC: 6107991.
DOI: 10.1093/infdis/jiy291.
Potency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice.
Suzuki M, Okamatsu M, Hiono T, Matsuno K, Sakoda Y
J Vet Med Sci. 2017; 79(11):1815-1821.
PMID: 28993601
PMC: 5709558.
DOI: 10.1292/jvms.17-0312.
Genetic characterization of an H2N2 influenza virus isolated from a muskrat in Western Siberia.
Gulyaeva M, Sharshov K, Suzuki M, Sobolev I, Sakoda Y, Alekseev A
J Vet Med Sci. 2017; 79(8):1461-1465.
PMID: 28690288
PMC: 5573837.
DOI: 10.1292/jvms.17-0048.
Development of a realtime RT-PCR assay for the rapid detection of influenza A(H2) viruses.
Komissarov A, Fadeev A, Kosheleva A, Sintsova K, Grudinin M
Mol Cell Probes. 2017; 35:57-63.
PMID: 28652020
PMC: 7126497.
DOI: 10.1016/j.mcp.2017.06.005.
Tackling influenza with broadly neutralizing antibodies.
Corti D, Cameroni E, Guarino B, Kallewaard N, Zhu Q, Lanzavecchia A
Curr Opin Virol. 2017; 24:60-69.
PMID: 28527859
PMC: 7102826.
DOI: 10.1016/j.coviro.2017.03.002.
Evaluation of multivalent H2 influenza pandemic vaccines in mice.
Lenny B, Sonnberg S, Danner A, Friedman K, Webby R, Webster R
Vaccine. 2017; 35(10):1455-1463.
PMID: 28189402
PMC: 5336516.
DOI: 10.1016/j.vaccine.2017.01.026.
Genetic and molecular characterization of a novel reassortant H2N8 subtype avian influenza virus isolated from a domestic duck in Zhejiang Province in China.
Wu H, Peng X, Peng X, Cheng L, Wu N
Virus Genes. 2016; 52(6):863-866.
PMID: 27379842
DOI: 10.1007/s11262-016-1368-0.
Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.
Wang W, Alvarado-Facundo E, Chen Q, Anderson C, Scott D, Vassell R
J Infect Dis. 2015; 213(3):403-6.
PMID: 26243315
PMC: 7313900.
DOI: 10.1093/infdis/jiv407.
H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.
Isakova-Sivak I, Stukova M, Erofeeva M, Naykhin A, Donina S, Petukhova G
Hum Vaccin Immunother. 2015; 11(4):970-82.
PMID: 25831405
PMC: 4514355.
DOI: 10.1080/21645515.2015.1010859.
Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression.
Dlugolenski D, Jones L, Howerth E, Wentworth D, Tompkins S, Tripp R
J Virol. 2015; 89(10):5651-67.
PMID: 25762737
PMC: 4442520.
DOI: 10.1128/JVI.00087-15.
Assessment of transmission, pathogenesis and adaptation of H2 subtype influenza viruses in ferrets.
Pappas C, Yang H, Carney P, Pearce M, Katz J, Stevens J
Virology. 2015; 477:61-71.
PMID: 25659818
PMC: 5804491.
DOI: 10.1016/j.virol.2015.01.002.
